本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tenaya Therapeutics Inc

0.6751
-0.0178-2.57%
成交量:150.41萬
成交額:101.94萬
市值:1.51億
市盈率:-1.27
高:0.7084
開:0.6979
低:0.6601
收:0.6929
52周最高:2.35
52周最低:0.5316
股本:2.24億
流通股本:2.23億
量比:0.86
換手率:0.67%
股息:- -
股息率:- -
每股收益(TTM):-0.5333
每股收益(LYR):-0.5922
淨資產收益率:-121.86%
總資產收益率:-47.91%
市淨率:2.18
市盈率(LYR):-1.14

資料載入中...

2024/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/07/25

重要事件披露

Form 8-K - Current report
2024/06/27

重要事件披露

Form 8-K - Current report
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/03/18

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/31

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/08

重要事件披露

Form 8-K - Current report